DS-1040b

DRUG5 trials

Sponsors

Daiichi Sankyo

Conditions

Acute Ischemic StrokeDrug InteractionHealthyPulmonary EmbolismThrombotic Disease

Phase 1

DS1040b/Aspirin Drug/Drug Interaction Study

CompletedNCT02071004

Daiichi SankyoAcute Ischemic Stroke

Start: 2014-01-31End: 2014-02-28Updated: 2018-12-24

Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects

CompletedNCT02560688

Daiichi SankyoDrug Interaction

Start: 2015-12-31End: 2016-03-31Updated: 2018-12-24

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

CompletedNCT02586233

Daiichi SankyoAcute Ischemic Stroke, Thrombotic Disease

Start: 2015-09-30End: 2019-08-13Updated: 2020-09-09

Study of the Effects of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of DS-1040b

CompletedNCT02647307

Daiichi SankyoHealthy

Start: 2016-02-29End: 2016-06-30Updated: 2018-12-24

Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

CompletedNCT02923115

Daiichi SankyoPulmonary Embolism, Thrombotic Disease

Start: 2016-06-23End: 2019-08-05Updated: 2023-04-19

Related Papers

Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic Stroke.

2022-01-217 citations

Safety and Pharmacokinetics of DS‐1040 Drug‐Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin

The Journal of Clinical Pharmacology2020-02-274 citations